
Cancer News
Alzheimer’s drug trial results hailed as ‘revolutionary
| December 4, 2022
Clinical specialists hailed the outcomes of a research of an experimental Alzheimer’s medicine called Lecanemab, which slowed down cognitive decline in a very closely seen test yet may
Read More

